Artificial pancreas safe, effective in early study.
Eric Renard, MD and colleagues at Lapeyronie Hospital in Montpelier, France working with investigators at Medtronic MiniMed of Northridge, CA tested the artificial pancreas in type 1 (insulin-dependent) diabetics with relatively stable disease. The device consists of an insulin reservoir implanted in the tissue lining the abdominal cavity and connected to a sensor implanted in the jugular vein in the neck. When the sensor detects an increase in blood glucose, the reservoir delivers the required amount of the sugar-regulating hormone. The reservoir requires insulin refills every month or so.
Because of the accuracy of the sensor, which measures glucose levels as many as 288 times during a 24-hour period, Renard said that blood glucose levels were controlled more than 60% of the time in the test patients, compared with 25% of the time in patients using injectable insulin.
|Printer friendly Cite/link Email Feedback|
|Comment:||Artificial pancreas safe, effective in early study.|
|Date:||Jun 30, 2002|
|Previous Article:||Two researchers charged with theft of genes that showed promise in creating new transplant drugs.|
|Next Article:||New studies bolster promise of both adult and embryonic stem cells.|